Israel - English - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

Israel - English - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israel - English - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

United Kingdom - English - myHealthbox

dawa limited - sulfamethoxazole/trimethoprim - tablets - 800mg/160mg - combinations of sulfonamides and trimethoprim, incl. derivatives - indicated for the treatment of the following infections in adults and adolescents when owing to sensitive organisms (see section 5.1): treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis treatment and prophylaxis of toxoplasmosis treatment of nocardiosis the following infections may be treated with co-trimoxazole tablets where there is bacterial evidence of sensitivity to co-trimoxazole tablets and good reason to prefer the combination of antibiotics in co-trimoxazole tablets to a single antibiotic: acute uncomplicated urinary tract infection acute otitis media acute exacerbation of chronic bronchitis

United Kingdom - English - myHealthbox

aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 80mg/400mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis

Kenya - English - Pharmacy and Poisons Board

tablets (india) limited. no 72 marshalls road chennai 600008 - co-trimoxazole tablets - tablet - trimethoprim bp 80 mg sulphamethoxazole bp 400 mg - antibacterials for systemic use: combinations of

Kenya - English - Pharmacy and Poisons Board

aurochem laboratories (india) pvt. ltd 8, palghar taluka industrial co-op. estate - digoxin 0.25mg tablets - tablet - digoxin 0.25mg tablets - cardiac glycosides: digitalis glycosides

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - ramipril - tablets - 1.25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - ramipril - tablets - 2.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - ramipril - tablets - 5 milligram